Page 56

Proefschrift binnenwerk Manon Ernst_DEF.indd

C H A P T E R   3   References   1.   Argente  J,  Mehls  O,  et  al.  Growth  and  body  cpmposition  in  very  young  SGA  children  Pediatr  Nephrol   2010;  25:679-­‐685.   2.   Centraal   Begeleidingsorgaan   voor   de   Intercollegiale   Toetsing.   Consensus   Diagnostiek   kleine   lichaamslengte  bij  kinderen;  1996.   3.   Boot  AM,  Engels  MA,  et  al.  Changes  in  bone  mineral  density,  body  composition,  and  lipid  metabolism   during   growth   hormone   (GH)   treatment   in   children   with   GH   deficiency.   J   Clin   Endocrinol   Metab   1997;  82:2423-­‐2428.   4.   Lapillonne   A,   Braillon   P,   et   al.   Body   composition   in   appropriate   and   in   small   for   gestational   age   infants.  Acta  Paediatr    1997;  86(2):196-­‐200.   5.   Willemsen   RH,   Arends   NJT,   et   al.   Long-­‐term   effects   of   growth   hormone   (GH)   treatment   on   body   composition   and   bone   mineral   density   in   short   children   born   small-­‐for-­‐gestational-­‐age:   six-­‐year   follow-­‐up  of  a  randomized  controlled  GH  trial.  Clinical  Endocrinology  2007;  67:485-­‐492.   6.   Snel   YE,   Doerga   ME,   et   al.   Resting   metabolic   rate,   body   composition   and   related   hormonal   parameters   in   growth   hormone-­‐deficient   adults   before   and   after   growth   hormone   replacement   therapy.  Eur  J  Endocrinol  1995;  133:445-­‐450.   7.   Roemmich   JN,   Huerta   MG,   et   al.   Alterations   in   body   compositions   and   fat   distribution   in   growth   hormone-­‐deficient   prepubertal   children   during   growth   hormone   therapy.   Metabolism   2001;   50:537-­‐547.   8.   Collipp   PJ,   Curti   V,   et   al.   Body   composition   changes   in   children   receiving   human   growth   hormone.   Metabolism  1973;  22:589-­‐595.   9.   Gregory  JW,  Greene  SA,  et  al.  Changes  in  body  composition  and  energy  expenditure  after  six  weeks'   growth  hormone  treatment.  Arch  Dis  Child  1991;  66:  598-­‐602.   10.   Hassan  M,  Kohno  H,  et  al.  Body  composition,  atherogenic  risk  factors  and  apolipoproteins  following   growth  hormone  treatment.  Acta  Paediatr  1996;  85:899-­‐901.   11.   Leger   J,   Carel   C,   et   al.   Magnetic   resonance   imaging   evaluation   of   adipose   tissue   and   muscle   tissue   mass   in   children   with   growth   hormone   (GH)   deficiency,   Turner’s   syndrome,   and   intrauterine   growth   retardation   during   the   first   year   of   treatment   with   GH.   J   Clinical   Endocrinol   Metab   1994;   78:904-­‐909.   12.   Vaisman   N,   Zadik   Z,   et   al.   Changes   in   body   composition,   resting   energy   expenditure,   and   thermic   effect  of  food  in  short  children  on  growth  hormone  therapy.  Metabolism  1994;    43:1543-­‐1548.   13.   Hoos   MB,   Westerterp   KR,et   al.   Short-­‐term   effects   of   growth   hormone   on   body   composition   as   a   predictor  of  growth.  J  Clin  Endocrinol  Metab  2003;  88:2569-­‐2572.   14.   Gerver  WJM,  de  Bruin  R:  Paediatric  Morphometrics,  a  reference  manual  (second  extended  edition).   in  Universitaire  pers  Maastricht.  Maastricht;  2004.   15.    Fredriks  AM:  Growth  Diagrams.  Fourth  Dutch  Nation-­‐Wide  Survey,  1997.  Thesis,  Leiden  University   2004;  258.       16.   Westerterp  KR,  Wouters  L,  et  al.  The  Maastricht  protocol  for  the  measurement  of  body  composition   and  energy  expenditure  with  labeled  water.  Obes  Res  1995;  3:49-­‐57.   17.   Ranke   MB,   Guilbaud   O:   Growth   response   in   prepubertal   children   with   idiopathic   growth   hormone   deficiency  during  the  first  two  years  of  treatment  with  human  growth  hormone.  Analysis  of  the  Kabi   Pharmacia  International  Growth  Study.  Acta  Paediatr  Scand  Suppl    1991;  379:90-­‐115.   18.   Furtado  AC,  Castro  LC,  et  al.  Clinical  predictors  of  growth  response  in  the  first  year  of  treatment  with   a  fixed  dose  of  growth  hormone  in  children  born  small  for  gestational  age.  Arq  Bras  Endocrinol  Me-­‐ tabol  2010;  54(5):443-­‐448.   19.   Ranke  B,  Lindberg  A,  et  al.  Prediction  of  response  to  growth  hormone  treatment  in  short  children,   born   small   for   gestational   age:   Analysis   of   data   from   KIGS   (Pharmacia   international   growth   data   base).  J  Clinical  Endocrinol  Metab  2003;  88  (1):125-­‐131.   20.   Zegher  de  F,  Francois  L,  et  al.  Growth  hormone  treatment  of  short  children  born  small  for  gestational   age.  Trends  Endocrin  Metab  1998;  9(6):233-­‐237.   21.   Volkl  TM,  Schwobel  K,  et  al.  Spontaneous  growth  hormone  secretion  and  IGF1:IGFBP3  molar  rations   in  children  born  small  for  gestational  age  (SGA).  Growth  Horm  IGF  Res  2004;  14(6):455-­‐461.   54    


Proefschrift binnenwerk Manon Ernst_DEF.indd
To see the actual publication please follow the link above